False Claims Act Insights - DOJ’s Reliance on FCA to Pursue Covid-Related Fraud
The Presumption of Innocence Podcast: Episode 20 - Pitfalls and Perils: Employee Retention Credit Enforcement Trends
Telehealth Risk Report: What the Government Found
Podcast: Hot Areas in COVID-19 Enforcement, Testing, and Funding - Diagnosing Health Care
Navigating Potential COVID Relief and Healthcare Fraud Issues
Health Care Practices: Can They Seek Employee Retention Credits Based on Harm Caused By COVID-19?
Credit Eco to Go Podcast - Not a Normal Mortgage Crisis: How the Mortgage Industry Weathered the Pandemic
Stephen Shaver on CARES Act Relief Funds and Healthcare Organizations
Labor & Employment Podcast Series, Biden’s First 100 Days: A Check-In for Employers.
Not a Normal Mortgage Crisis: How the Mortgage Industry Weathered the Pandemic
The Year Ahead: COVID-19's Impact on the Employee Benefits Value Proposition
PPP Loans: Frequently Asked Questions
Paycheck Protection Program – Common Questions and Updated Guidance
COVID-19 Hospice How-To Series: The Latest on Using and Reporting Your Provider Relief Funds
When Is Form 1099-C Required of Lenders? [More with McGlinchey, Ep. 16]
PODCAST: Williams Mullen's Benefits Companion - New Round of COVID-19 Relief Expands Assistance for Employers
2021: The Year Ahead for Employers
PPP Loan Recipients at Risk: Part One
Slamming the door on 2020 and looking ahead to 2021
Dealing with The CARES Act and the Current Status of Offsets in Pennsylvania Workers Compensation
Johnson & Johnson Challenges the Constitutionality of FCA $1.6 Billion Verdict - Following a record $1.6 billion jury verdict for off-label promotion of HIV drugs Prezista and Intelence, Johnson & Johnson (J&J) subsidiary...more
We are pleased to bring you our 12th annual Healthcare Fraud & Abuse Review. Our Review provides comprehensive coverage of the most significant civil and criminal enforcement issues facing healthcare providers. Each year, we...more
We are pleased to bring you our 11th annual Healthcare Fraud & Abuse Review. Our Review provides comprehensive coverage of the most significant civil and criminal enforcement issues facing healthcare providers. Each year, we...more
Takeaways - Despite predictions that the Biden administration would devote increased enforcement resources to the life sciences industry broadly, so far, the FDA and DOJ have focused their efforts on COVID-related conduct. ...more
Ensuring compliance with the False Claims Act has never been more important for healthcare providers. By March 2020, we saw healthcare professionals standing at the forefront of one of the greatest health crises in a...more
As COVID-19 continues to ravage the United States, the Department of Justice (DOJ) has recently announced its new National Rapid Response Strike Force within the Health Care Fraud Unit to investigate and prosecute fraud cases...more